Literature DB >> 24995506

Hybrid polymer micelles capable of cRGD targeting and pH-triggered surface charge conversion for tumor selective accumulation and promoted uptake.

Xiuli Hu1, Xingang Guan, Jing Li, Qing Pei, Ming Liu, Zhigang Xie, Xiabin Jing.   

Abstract

This study presents both tumor-targeting ligands (cRGD) and pH-activated surface charge-conversional moiety (imidazole) decorated micelles for Dox delivery. cRGD is expected to induce preferential tumor accumulation, while imidazole switches on positive charge in a tumor acid environment, which leads to enhanced micelle uptake by tumor cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24995506     DOI: 10.1039/c4cc04056b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

1.  A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.

Authors:  Zhuxian Zhou; Zhen Han; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

2.  Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.

Authors:  Jinming Zhang; Min Zhang; Juan Ji; Xiefan Fang; Xin Pan; Yitao Wang; Chuanbin Wu; Meiwan Chen
Journal:  Pharm Res       Date:  2015-07-07       Impact factor: 4.200

3.  Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy.

Authors:  Chia-Chian Hung; Wen-Chia Huang; Yi-Wen Lin; Ting-Wei Yu; Hsin-Hung Chen; Sung-Chyr Lin; Wen-Hsuan Chiang; Hsin-Cheng Chiu
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

Review 4.  Recent Advances in Tannic Acid (Gallotannin) Anticancer Activities and Drug Delivery Systems for Efficacy Improvement; A Comprehensive Review.

Authors:  Rana A Youness; Rabab Kamel; Nermeen A Elkasabgy; Ping Shao; Mohamed A Farag
Journal:  Molecules       Date:  2021-03-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.